$1.55 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: $1.55 Billion

As of May 2022 ImmunityBio has a market cap of $1.55 Billion. This makes ImmunityBio the world's 3837th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2022

Year Market cap Change
2022$1.38 B-42.58%
2021$2.41 B

End of Day market cap according to different sources

On May 19th, 2022 the market cap of ImmunityBio was reported to be:

$1.48 Billion
by Nasdaq
$1.48 Billion
by CompaniesMarketCap
$1.48 Billion
by Yahoo Finance
$1.48 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$0.13 B-91.45%๐Ÿ‡บ๐Ÿ‡ธ USA